Product NDC 17772-0132

5 indexed presentations under this Product NDC family.

Reference only for licensed healthcare facilities. These listings support exact-NDC identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review package-specific NDC rows, compare configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Request a Quote Review

Drug Catalog Search | Request a Quote Review

Family context

Product NDC 17772-0132 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before a quote review is requested.

Family size: 5 indexed presentations.
Generic family: viloxazine hydrochloride.
Primary dosage form: Capsule.
Common strength: 150 mg / 1.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

Manufacturers shown: Supernus Pharmaceuticals, Inc.
Dosage forms shown: Capsule.
Package quantities: 100 Capsule, Extended Release, 30 Capsule, Extended Release, 60 Capsule, Extended Release, 7 Capsule, Extended Release, and 90 Capsule, Extended Release.

Manufacturer identifiers

Manufacturer information is shown for product identification only.

Supernus Pharmaceuticals, Inc

Exact-item pages in this family

Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 100 Capsule, Extended ReleaseNDC 17772-0132-01 | 100 Capsule, Extended Release | Supernus Pharmaceuticals, Inc

Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 30 Capsule, Extended ReleaseNDC 17772-0132-30 | 30 Capsule, Extended Release | Supernus Pharmaceuticals, Inc

Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 60 Capsule, Extended ReleaseNDC 17772-0132-60 | 60 Capsule, Extended Release | Supernus Pharmaceuticals, Inc

Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 7 Capsule, Extended ReleaseNDC 17772-0132-07 | 7 Capsule, Extended Release | Supernus Pharmaceuticals, Inc

Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 90 Capsule, Extended ReleaseNDC 17772-0132-90 | 90 Capsule, Extended Release | Supernus Pharmaceuticals, Inc

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Search DailyMed labelingOpens DailyMed search results.

Showing page 1 of 1


Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 100 Capsule, Extended Release	17772-0132-01	150 mg / 1	Capsule	100 Capsule, Extended Release
Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 30 Capsule, Extended Release	17772-0132-30	150 mg / 1	Capsule	30 Capsule, Extended Release
Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 60 Capsule, Extended Release	17772-0132-60	150 mg / 1	Capsule	60 Capsule, Extended Release
Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 7 Capsule, Extended Release	17772-0132-07	150 mg / 1	Capsule	7 Capsule, Extended Release
Qelbree - Viloxazine hydrochloride 150 mg / 1 Capsule 90 Capsule, Extended Release	17772-0132-90	150 mg / 1	Capsule	90 Capsule, Extended Release

Page 1 of 1

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.